We advised the sole bookrunning manager in connection with the IPO

Davis Polk advised the sole bookrunning manager in connection with the initial public offering of 6,000,000 ordinary shares of JATT II Acquisition Corp for aggregate proceeds of $60 million. The shares are listed on the Nasdaq Global Market under the symbol “JATT.”

JATT II Acquisition Corp was formed for the purpose of effecting a business combination with one or more businesses. The SPAC intends to focus its search on healthcare and healthcare-related businesses, with a primary emphasis on biotechnology and broader life sciences.

The Davis Polk capital markets team included partner Derek Dostal and associates Robert Van de Mark and Paul M. Sessa. Counsel Marcie A. Goldstein provided FINRA advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post